Back
SEARCH AND PRESS ENTER
Recent Posts

Value-Based Care: It Doesn’t Mean What You Think

By Thomas Davis, MD. FAAFP

Value-Based Care.

Among clinicians it’s become a dirty word. It’s come to mean a payment model in which total provider compensation is adjusted based on meeting specific measures for specific groups of attributed patients. Ostensibly created to decrease costs and promote health, in reality the selection of those measures is politically driven, their definitions overly complex, and the goals themselves unattainably high. It’s seen by clinicians, quite rightly, as a way to justify the ongoing suppression of provider compensation. The model’s near-universal use has understandably come to be treated with cynicism and disdain. So, when CMS announced earlier this decade that by 2030 the care for all Medicare and most Medicaid beneficiaries will be paid for through a spectrum of value-based care arrangements, fear was added the disdain.

Except, the model just described, the model most closely associated with the term “Value-Based Care” is not Value- Based Care at all. It’s merely a bastardized form of Fee-For- Service. Call it “Metric-Based Care.”

Real Value-Based Care is an entirely novel payment model thirty years in the making. It is specifically designed to reduce the growth in the rate of increase in care costs, to bend the “cost curve.” For the Federal government, it does so by shifting the financial risk of covering Medicare and Medicaid care costs from the US Treasury onto the vast pool of trillions of dollars which underpins the global liability market. If it doesn’t shift risk, it’s not Value-Based Care.

Once it’s universal and mandatory, it will change the shape of our world. And those who understand it will benefit the most.

A “Risk-Shifting” Model

Whenever a third party is engaged to cover healthcare costs, there are two specific terms which must be considered, the actuarial expense and the actual expense. These can be more simply thought of as what care “should” cost and what care “does” cost. In healthcare, these two numbers can be very different.

Ideally, the third-party payer will set specific limits on the amount paid for an episode of care. But healthcare is an unusual service; emotionally charged, heavily litigated, and difficult to externally value. The result is a strong predilection for generating its own demand. The more a clinician does, the more a clinician can justify doing, generating substantial additional liability for any guarantor. Surveillance imaging. Additional therapy. Multiple follow ups of incidental findings. These are gray expenses, historically very difficult to control at a distance.

Since the advent of third-party payment, medical care has been, in fact, one long “cost struggle” between the payer and the provider. The tighter the payer tries to regulate and reduce expenses, the more aggressive the provider is in generating additional expense to compensate. The actuarial, or calculated, cost of care remains steady, while the actual cost of care soars.

In this conflict the provider has distinct advantages. Influential, trusted by the beneficiary, credentialled and present at the point of care, every new attempt at cost control can be countered by the provider with the delivery of additional care, causing care cost growth rates to accelerate faster with each attempt. And as individual providers have transitioned into corporate health systems skilled in billing, costs have increased even faster still. Guarantors have been forced to push back with ever more onerous cost control tools. The result is the unsustainably dystopian “system” of care delivery we suffer today.

But give CMS some credit. By the early 1990s, this was all clearly foreseen. Specifically, at that time, the government had spent a decade trying to curb cost growth by creating an entirely new measure of valuing medical service, the Resource-Based Relative Value Scale (RBRVS). Not only was it costly, it also miserably failed. Providers compensated for reduced payments by increasing utilization, and care costs only accelerated faster. CMS was forced to recognize that no modification of the FFS payment model was ever going to bend the cost curve downward. The provider’s advantage was simply too great. The result was a strategic decision, the existential impact of which we are feeling today.

A Major Change

The Federal Government decided to shift the financial risk for actual financial cost of care from itself onto someone else. CMS would still manage the program, and the Treasury would still fund the actuarial cost of care. But the difference between what care should cost and what care did cost would be shifted onto the shoulders of someone else.

The most likely candidates were the private risk-bearing entities offering commercial health insurance to businesses and the public. But those organizations knew quite well the FFS model was unsustainable. As huge as the opportunity might be, they would not accept such risk without some model that would allow them to actually control costs.

Enter the HMO.

In an HMO the beneficiary selects a specific clinician, called a primary care provider or PCP. The PCP coordinates all the beneficiaries’ covered care. What the PCP could not do, they referred out. To assist in cost-control, the PCP was given “gatekeeping” authority. Only care approved by the PCP themselves was covered by the payer. In exchange, the PCP is paid a single monthly stipend for each of those attributed patients. No additional FFS charges were allowed.

The model had been around for more than a century, but in its modern iteration, beneficiaries accepted the limitations in access in exchange for dramatically decreased premiums. Around 1990, the care cost rise in response to the introduction of RBVs was hitting full force, so commercial HMOs provided a popular alternative to standard insurance arrangements. In practice, the model proved devastatingly effective in reducing care costs. And for that reason, the care delivery industry worked hard to delegitimize it and make it politically unpalatable.

The Government Noticed

HMOs were far too toxic for CMS to implement directly. Consumers choosing HMOs to reduce their premiums was one thing, the government mandating them on seniors was something else. But HMOs did offer a path through which private insurers could reasonably expect to succeed where the FFS model had failed. And thus risk-shifting, christened in government-speak as “Value- Based Care” was born.

Insurers are “risk-bearing entities,” (RBEs). RBEs are tightly regulated business arrangements which promise to compensate their customers for certain losses incurred under defined circumstances in exchange for a fee. To ensure that they can pay off their claims, RBEs are required to hold aside a significant number of financial reserves invested in the safest assets. To further protect themselves, RBEs spread their liability and generate additional revenue on their reserves by reinsuring each other against losses, paying each other premiums to offset the expense of that risk. And then those reinsurance arrangements reinsure each other again. And so on, until our entire world is supported by one vast spiderweb of reinsurance arrangements, funded by trillions in reserves and all designed to support each other against excessive risk. Those reserves and the system it supported were more than robust enough to take on the financial risk of the government’s trillion-dollar healthcare promises. That is as long as they could make a profit from doing it.

Capping Resources

In its essentials, Value-Based Care for Medicare and Medicaid can be seen as a model which shifts the financial responsibility of the real cost of care from the US Treasury onto the shoulders of this vast insurance resource. Under FFS, there is no theoretical limit to the number of dollars a given beneficiary can generate for a provider. There’s certainly a practical limit for a specific clinician, but a health system employing thousands of clinicians can legitimately literally bill millions of dollars per patient per year. Add in illegitimate billings and the number can be much larger.

No longer.

Under VBC, the resources available to cover the annual care costs of a given beneficiary are capped, usually at around $15,000. Do more, and whoever is shouldering the risk bears the cost. Losses may be covered by reinsurance at first, but it will take only a few cycles of adverse experience before an underperformer is dropped like someone who has wrecked their car one too many times. As we will see, this funding transition from the bottomless, politically driven U.S. Treasury to a finite pool of dollars run for profit will have profound impacts which our industry has not yet begun to foresee.

Building The Model

CMS created what were essentially HMOs on steroids. CMS would pay a private insurer a guaranteed monthly payment for each beneficiary, one which would cover the actuarial cost of care, i.e. what the beneficiary’s care “should” cost. If the beneficiary’s actual care costs came in under the payment, the insurer could keep the difference as profit. If not, the insurer would be responsible for any deficit. To ensure he stayed in business, the insurer would re-insure themselves against any adverse experience just like they would for any other coverage. Margins could be tight, but given the size of the program, an insurer who controlled costs could do very well indeed.

But shifting risk onto the insurers was only part of the battle. A successful model depended on motivated beneficiaries, voluntarily engaged. HMOs had attracted beneficiaries due to their much lower premiums. CMS did not have those tools, but they could broaden benefits to attract beneficiaries into the program. It was an approach which proved very effective and when the program was announced enrollment far exceeded expectation.

Further changes were required to get the providers on board. HMOs had a bad reputation for both generating operational challenges and parsimonious monthly payments. So, to ensure the model was attractive, CMS liberalized contracting rules so that insurers could shift some or even all the financial risk onto the providers themselves, especially the PCPs. PCPs were given gatekeeping authority to control costs; no outside care could be sought by a beneficiary without their approval. And such authority was needed as the entirety of the PCP’s compensation would depend on managing the care of a group of patients for fewer dollars than the government paid and keeping the difference.

In this model, all the advantages providers possessed in the FFS “cost struggles” against payers would be stood on their heads. The insurers would now have an agent, on the ground, at the point of care with fully aligned incentives to remove over-utilization and promote health. And since the cost benefits of good health multiplied over time, PCPs were incentivized to maintain long-term relationships with the patients who they helped stay healthy.

By putting PCPs at financial risk for their own labor, by essentially treating the entirety of a beneficiary’s care as one giant case rate, all the incentives for providers to over-utilize would be removed. PCPs would only generate a financial return if they promoted health and optimized care.

It was an inspired design.

An Excellent Start

Insurers, at first, wanted no part of taking risk. The early arrangements had them take a fixed percentage of the government’s monthly payment. They passed on the rest to the attributed PCP or their employers to form a pool of dollars from which care costs could be paid.

The PCPs who took such risk did amazingly well. There was so much fat in the system and the bias for over-utilization so strong that immense reductions in costs could be realized with very little effort. Most such PCPs reinsured themselves against catastrophic loss using surprisingly affordable stop- loss insurance protection. The result was compensation many multiples of what they would have earned under FFS. And the overall savings to CMS for those beneficiaries was beyond any projections.

Interestingly, health systems who also took the opportunity did quite poorly. They paid PCPs RVU rates, perpetuating the conflicting incentives of FFS. The PCPs had no incentives to reduce costs, those health systems were quickly in a deficit, lost their reinsurance coverage, and dropped out.

With experience, payers became more comfortable to accepting risk under the program. They also understood that to succeed, PCPs must be directly tied to the financial performance of their attributed patients. Most contracts today are “shared-risk,” where the insurer and the provider each shoulder financial responsibility in approximately equal measure. Such contracts usually mandate risk-share compensation arrangements with PCPs, understanding that the health systems default approach of treating such clinicians as piece-workers results in losses for everyone under VBC.

Optimized for Growth

It only took a couple of years’ experience for CMS to recognize that it had innovated a winner. Their pilot was quickly codified into law and a significant number of beneficiaries and providers enrolled. But as the first movers and early adopters fully came on board, growth soon stalled. So, CMS began a process of optimization which continues to this day.

To add resources responsibly to the program, they tied the monthly premium CMS paid to the insurers to the beneficiary’s own disease burden as defined by their submitted ICD codes. This had the unfortunate effect of putting the PCPs and insurers at moral hazard as they could increase their revenue by fraudulently submit codes that weren’t supported.

For decades, this politically protected fraud more than masked any cost savings. It was not until the recent advent of AI-driven audits that fraud began to be brought under control, and the bending of the cost curve again began to be seen. Risk-coding did, though, have the salutary effect of incentivizing health systems back into the game, as most already had coding fraud embedded in the business model. This increased the number of participating providers and broadened public acceptance.

A quality rating period with bonuses was also introduced to maintain standards. It too was the source of much fraud, but it also did much to enhance the reputation of the model.

Helping Along The Journey

CMS also realized that most of its contractors weren’t capable of accepting the full risk of care costs. So, CMS created a steppingstone of payment arrangements designed to slowly move organizations forward. You know them as Accountable Care Organizations or ACO. Starting with shared savings, where only 5% of the risk is shifted, ACOs offer a spectrum of risk-sharing relationships specifically designed to nurture contractors and move them along the path to CMS’ ultimate goal; accepting full financial risk for the cost of care.

When seen in the context of government policy and fiscal reality, the journey and goal of Value-Based Care becomes clear. And despite wild political swings, CMS has stuck with it. First in 2015 and as recently as 2023, CMS explicitly stated that by 2030, all of Medicare and most of Medicaid will be paid for under some form of attributed, risk-shifting arrangement, with the unstated goal of moving everyone to full-risk as rapidly as possible. And since under the ACA the commercial insurers are essentially government utilities, where Medicare and Medicaid go, the private payers will quickly follow. VBC will be normalized, universal and mandatory.

That’s Value-Based Care.

Limited resources. Shifted risk. Realigned incentives. Among the implications

  • Coordinating delivery and promoting healthy habits will become more valuable than delivering care.
  • Interventions, including preventative ones, will be judged on efficacy and not on how much revenue they can generate.
  • Compensation between primes and specialists will be realigned. To succeed at VBC, PCPs will have to be placed at some financial risk for their care decisions with the opportunity to earn commensurate financial rewards.
  • PCPs skilled in patient engagement and management will become more valuable. Specialty clinicians skilled in procedures relatively less so; to the point that their relative compensation will approach parity.
  • Inpatient and specialty services will transform from centers of revenue to centers of expense, necessary evils.
  • Innovation in care delivery, currently stagnant, will be rewarded; over-investment in expensive, gleaming palaces of healing punished.
  • Because the value of each beneficiary is capped, gross revenue can only be increased by increasing the number of beneficiaries attributed to a given provider. Competition for beneficiaries among the members of the currently consolidated medical care delivery cartel within a given market will become fierce. The subtle collegial cooperation and collusion of today will become a thing of the past.
  • Emphasis and incentives for healthy living will take the lead. Since healthcare represents a lion’s share of the economy, every other sector; agriculture, leisure, advertising, will also undergo profound change, reorienting towards real health.
  • Opportunities will appear for specialty groups to accept case rates for the delivery of a specific set of services for a defined population over time.
  • As interventions decrease and attributed physicians bear the expense of adverse outcomes, Iatrogenic injuries to patients will greatly diminish.

And perhaps most importantly of all, existing health systems will not survive. Most of their care delivery infrastructure; physical, managerial, and mindset, is mono-culture, entirely devoted to FFS and thus through-put. Those processes are the antithesis of what is required for VBC success. Their clinical advisors are chiefly specialists, who are focused on their dwindling piece of the compensation pie. The debt their FFS free cash-flow has enabled, invested in commercial real estate and other dead-end ventures will become insupportable.

Much like Amazon replacing Sears, it will be outside providers and organizations, innovating de novo, without legacy costs and mindsets, which will succeed in this new world of VBC.

Skepticism

The easiest refutation of the doubters lies in the financing of Medicare itself. Seven-year rolling Medicare expenditures alone are predicted to almost treble by 2037 to $15T. The real number is probably much more, as such estimates have always fallen far short of the mark. Care payments are already unsustainably low. Clinicians who can are fleeing to the much more lucrative model of cash pay. The industry has already reached the point that the dollars available are insufficient to safely staff for services. What will happen when the government has to print trillions more?

So, if the government wishes to continue the political benefits of offering care coverage, and it very much does, it must find a sustainable path to pay for it. 30 years ago, it chose Value- Based Care. If that choice survived the wild political swings since, it’s much more reasonable than not to assume it will follow fully through.

What You Can Do

Here’s your action items to prepare yourself

  • Increase your value by developing additional services with valuable outcomes which you can offer cost-effectively
  • Understand your role in the new, cost-shifted world. Specialists transform into centers of expense. Their value lies in decreasing that expense. That means less doing and more sharing of expertise through collaboration. Build those collegial networks and nurture your reputation as a collaborator.
  • Clinicians, especially PCPs, should educate themselves on the skills of influence and persuasion. It will not be enough to provide excellent care; you will be compensated based on how effectively you can convince your patients to comply with your recommendations. Taking the Dale Carnegie Course is the best place to start. That will help specialists with the previous bullet point as well.
  • Build an understanding of actuarial science. Under VBC, real financial security can be found in accepting a portion of the cost risk for a defined portion of those costs; e.g. cardiologists caring for a group of CHF patients or surgical orthopedic care for a given population. The ability to anticipate costs and price such arrangements correctly, rare among clinicians, will be a decisive advantage.
  • If all this is too overwhelming, consider taking your expertise outside to the cash pay world.

The Only Prison is Fear

Chances are in discussions of Value-Based Care you have heard nothing of its implications, certainly nothing offering this level of understanding. And it’s easy to understand why.

Denial.

Our entire industry from training to practice is predicated on the old FFS-based, through-put model, the antithesis of this new, cost-shifting world. There is literally no saving any portion of it, so rather than prepare, all the incumbents have left is to delude themselves that none of this will come to pass.

Fortunately, for those with understanding and vision the opportunities are immense. The re-aligned incentives will not only get them off the care-delivery treadmill and bring about a renaissance in their personal and professional mission, but it will also promote the one result which matters most.

The well-being of our patients.

Thomas Davis, MD. FAAFP

Tom Davis MD FAAFP was among the first signers of the first full-risk Medicare Advantage type plan ever offered. With it he created the nation’s first Value-Based health system, Patients First Healthcare of Washington, Missouri. For decades, he has been the country’s foremost clinical Value-Based Care consultant. He currently shares his expertise for free at his Value-Based Care Success Community found at VBSC.com

Leave Your Comment